[Principle of immunoregulation in the treatment of chronic inflammatory rheumatism].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000906:Antibodies / Q000008:administration & dosage; D002908:Chronic Disease; D005246:Feedback; D006801:Humans; D007111:Immunity, Cellular / Q000528:radiation effects; D007113:Immunity, Innate; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000276:immunology* / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology* / Q000528:radiation effects; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology / Q000528:radiation effects; D013946:Thymopoietins / Q000627:therapeutic use; D014165:Transfer Factor / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000906:Antibodies; D007166:Immunosuppressive Agents; D013946:Thymopoietins; D014165:Transfer Factor; D007978:Levamisole; D007372:Interferons
Principiul imunoreglării în tratamentul reumatismelor inflamatorii cronice.